SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $516,000 | +75.5% | 6,448 | +65.5% | 0.00% | +50.0% |
Q3 2019 | $294,000 | -13.0% | 3,897 | +75.6% | 0.00% | 0.0% |
Q2 2019 | $338,000 | +30.0% | 2,219 | +1.8% | 0.00% | 0.0% |
Q1 2019 | $260,000 | +76.9% | 2,179 | +60.6% | 0.00% | +100.0% |
Q4 2018 | $147,000 | -50.2% | 1,357 | -26.0% | 0.00% | -50.0% |
Q3 2018 | $295,000 | +217.2% | 1,833 | +46.9% | 0.00% | +100.0% |
Q2 2018 | $93,000 | 0.0% | 1,248 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $93,000 | -40.0% | 1,248 | -55.1% | 0.00% | 0.0% |
Q4 2017 | $155,000 | -19.7% | 2,782 | -34.7% | 0.00% | -50.0% |
Q3 2017 | $193,000 | +227.1% | 4,262 | +140.9% | 0.00% | +100.0% |
Q2 2017 | $59,000 | +18.0% | 1,769 | +3.9% | 0.00% | 0.0% |
Q1 2017 | $50,000 | +51.5% | 1,702 | +41.4% | 0.00% | – |
Q4 2016 | $33,000 | -87.8% | 1,204 | -72.7% | 0.00% | -100.0% |
Q3 2016 | $271,000 | +191.4% | 4,404 | -10.0% | 0.00% | +300.0% |
Q2 2016 | $93,000 | +151.4% | 4,892 | +158.6% | 0.00% | 0.0% |
Q1 2016 | $37,000 | -49.3% | 1,892 | -0.7% | 0.00% | 0.0% |
Q4 2015 | $73,000 | +17.7% | 1,905 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $62,000 | +59.0% | 1,905 | +49.2% | 0.00% | 0.0% |
Q2 2015 | $39,000 | +129.4% | 1,277 | 0.0% | 0.00% | – |
Q1 2015 | $17,000 | +325.0% | 1,277 | +361.0% | 0.00% | – |
Q4 2014 | $4,000 | -33.3% | 277 | -7.7% | 0.00% | – |
Q4 2013 | $6,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |